FREMONT, Calif., Feb. 28, 2024 Cytek® Biosciences, Inc. , a leading cell analysis solutions company, today reported financial results for the fourth quarter and year ended December 31, 2023..
FREMONT, Calif., Aug. 08, 2023 (GLOBE NEWSWIRE) Cytek® Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB) today reported financial results for the second quarter ended June 30, 2023.
Cytek® Biosciences (CTKB) Announces $50M Share Buyback streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.